Author:
Rye Morten Beck,Bertilsson Helena,Andersen Maria K.,Rise Kjersti,Bathen Tone F.,Drabløs Finn,Tessem May-Britt
Funder
Samarbeidsorganet mellom Helse Midt-Norge RHF og NTNU
Kreftforeningen
PhD position from strategic funding ISB, Norwegian University of Science and Technology NTNU
PhD position from Enabling Technologies, Norwegian University of Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference66 articles.
1. Swyer GIM. The cholesterol content of normal and enlarged prostates. Cancer Res. 1942;2:372–5.
2. Meller S, Meyer HA, Bethan B, Dietrich D, Maldonado SG, Lein M, Montani M, Reszka R, Schatz P, Peter E, et al. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and Gleason score-specific metabolomic alterations in prostate cancer. Oncotarget. 2016;7(2):1421–38.
3. Freeman MR, Solomon KR. Cholesterol and prostate cancer. J Cell Biochem. 2004;91(1):54–69.
4. Krycer JR, Brown AJ. Cholesterol accumulation in prostate cancer: a classic observation from a modern perspective. Biochim Biophys Acta. 2013;1835(2):219–29.
5. Pelton K, Freeman MR, Solomon KR. Cholesterol and prostate cancer. Curr Opin Pharmacol. 2012;12(6):751–9.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献